Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News The Latest Analyst Ratings For Boston Scientific is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?
With a market cap of $155.2 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Based in ... Read More
A Glimpse Into The Expert Outlook On Boston Scientific Through 13 Analysts
Diving into Analyst Ratings: An In-Depth Exploration In examining recent analyst actions, we gain insights into how financial experts perceive Boston Scientific. The following summary outlines key ... Read More
Earnings Preview: Boston Scientific
This analysis delves into the latest insights on Boston Scientific. Analysts have given Boston Scientific a total of 13 ratings, with the consensus rating being Buy. The average one-year price ... Read More
Boston Scientific Corporation (BSX)
More than 70% of analysts covering Netflix have buy or overweight ratings on the video streaming service. Boston Scientific, Meta Platforms and Microsoft have been highlighted in this Investment ... Read More
Boston Scientific (NYSE:BSX) Beats Q1 Sales Targets, Next Quarter’s Sales Guidance is Optimistic
Medical device company Boston Scientific (NYSE:BSX) reported in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. Guidance for next quarter’s revenue was better than expected at $4.88 ... Read More
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Encompass Health (EHC) and Integer Holdings (ITGR)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX – Research Report), Encompass Health (EHC – Research Report) and Integer Holdings ... Read More
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results
Boston Scientific shares gained 2.4% to trade at $101.24 on Thursday. These analysts made changes to their price targets on Boston Scientific following earnings announcement. Baird analyst David ... Read More
NeuroOne Medical Technologies (NASDAQ:NMTC) and Boston Scientific (NYSE:BSX) Critical Comparison
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus